Liver ... and Onions

  • by: |
  • 11/25/2009

According to a technical amendment to FDA’s final rule for internal analgesics, acetaminophen products sold in stick packs and sachets must carry warnings about the risk of liver injury by April 29, 2010,.

Warnings on immediate containers such as sachets and stick packs are important because "consumers may routinely remove these packages from the outer carton and, therefore, fail to see the liver injury and stomach bleeding warning if they are only printed on the carton," FDA says in the technical amendment.

By requiring the stick pack/sachet warning, FDA refuses a request from manufacturers.

FDA acknowledged requests that the agency should exempt certain immediate containers from the labeling requirement because of limited space, but disagrees, saying stick packs and sachets have "adequate space to accommodate the required warnings."

Finally, FDA clarifies products with acetaminophen introduced within a year before the final rule's effective date - April 29, 2010 - must include a "see new warnings" flag for at least one year from the launch date.

Products launched after the effective date do not need the new warnings flag.

FDA maintains the rule will not have a "significant economic impact on a substantial number" of businesses.

According to the Tan Sheet, “Acetaminophen marketers could face more burdensome restrictions down the road, including removing certain doses from the market, if FDA follows the advice of an advisory panel convened in April to discuss ways to reduce the risk of hepatotoxicity related to the ingredient.”

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog